scispace - formally typeset
Open AccessJournal ArticleDOI

l-Arginine and COVID-19: An Update.

Reads0
Chats0
TLDR
In this paper, an updated systematic overview of the current evidence on the functional contribution of L-Arginine in COVID-19, describing its actions on endothelial cells and the immune system and discussing its potential as a therapeutic tool, emerged from recent clinical experimentations.
Abstract
l-Arginine is involved in many different biological processes and recent reports indicate that it could also play a crucial role in the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we present an updated systematic overview of the current evidence on the functional contribution of L-Arginine in COVID-19, describing its actions on endothelial cells and the immune system and discussing its potential as a therapeutic tool, emerged from recent clinical experimentations.

read more

Citations
More filters
Journal ArticleDOI

Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey

TL;DR: In this article , the authors designed a survey (LINCOLN: L-Arginine and Vitamin C improves Long-COVID), assessing several symptoms that have been associated with Long-CoVID to be administered nationwide to COVID-19 survivors; the survey also included effort perception, measured using the Borg scale.
Journal ArticleDOI

Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19

TL;DR: It is demonstrated for the first time that two specific microRNAs contained in circulating exosomes are functionally involved in thromboembolic events in COVID-19.
Journal ArticleDOI

Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial

TL;DR: In this paper , a single-blind randomized, placebo-controlled trial was conducted in adults aged between 20 and 60 years with persistent fatigue attending a post-acute COVID-19 outpatient clinic, where participants were randomized 1:1 to receive twice-daily orally either a combination of 1.66 g larginine plus 500 mg liposomal vitamin C or a placebo for 28 days.
Journal ArticleDOI

What should a family physician know about nutrition and physical exercise rehabilitation’ advices to communicate to ‘long-term COVID-19’ patients?

TL;DR: The CPR ‘minimal advice’ that should be provided by FPs managing ‘long-term Covid-19’ patients with incapacity and how these guidelines can relieve the mental and physical problems, improve immunity, and accelerate the recovery process of the patients are reported.
Journal ArticleDOI

Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy

William Durante
- 01 Mar 2022 - 
TL;DR:
References
More filters
Journal ArticleDOI

Nitric oxide synthases: regulation and function.

TL;DR: Nitric oxide (NO), the smallest signalling molecule known, is produced by three isoforms of NO synthase (NOS), which can be expressed in many cell types in response to lipopolysaccharide, cytokines, or other agents.
Journal ArticleDOI

Nitric oxide and the immune response

TL;DR: Its striking inter- and intracellular signaling capacity makes it extremely difficult to predict the effect of NOS inhibitors and NO donors, which still hampers therapeutic applications.
Journal ArticleDOI

Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release

TL;DR: The mechanism of mitochondrial RIRR highlights the central role of mitochondria-formed ROS, and all of the known ROS-producing sites and their relevance to the mitochondrial ROS production in vivo are discussed.
Related Papers (5)